Xenetic Biosciences, Inc. (XBIO)
USD 4.06
(3.05%)
USD 4.06
(3.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.11 Million | -4.64 Million | -4.73 Million | -4.26 Million | -6.39 Million | -6.46 Million |
| Net Income | -4.13 Million | -6.55 Million | -5.64 Million | -10.89 Million | -12.77 Million | -7.3 Million |
| Depreciation & Amortization | - | 27.04 Thousand | 35.48 Thousand | 28.83 Thousand | 27.48 Thousand | 15.82 Thousand |
| Deferred income taxes | - | - | -24.26 Thousand | -2.91 Million | 3.34 Million | - |
| Stock-based compensation | 283.08 Thousand | 511.48 Thousand | 410.43 Thousand | 468.91 Thousand | 853.51 Thousand | 1.42 Million |
| Change in working capital | -262.72 Thousand | -426.68 Thousand | 461.19 Thousand | -52.44 Thousand | -881.52 Thousand | -595.67 Thousand |
| Other non-cash items | 546.65 Thousand | 1.79 Million | 24.26 Thousand | 9.09 Million | 3.03 Million | -5231.00 |
| Investing Cash Flow | - | -500 Thousand | - | - | 2000.00 | 22.5 Thousand |
| Investments in PPE | - | -500 Thousand | - | - | - | - |
| Acquisitions | - | -500 Thousand | - | - | 2000.00 | 22.5 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 500 Thousand | - | - | 2000.00 | 22.5 Thousand |
| Financing Cash Flow | 16.00 | - | 11.45 Million | 5.42 Million | 16.12 Million | 1.48 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 1.29 Million | - | - | 3.03 Million | - |
| Common Stock Issuance | 16.00 | - | 11.45 Million | 5.42 Million | 16.12 Million | 1.48 Million |
| Other Financing Activities | -16.00 | - | 3679.00 | 5.42 Million | 16.12 Million | 1.48 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -263.57 Thousand | -347.94 Thousand | 457.13 Thousand | -378.11 Thousand | -227.96 Thousand | -343.87 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 845.00 | -78.73 Thousand | 4061.00 | 325.66 Thousand | -653.56 Thousand | -251.79 Thousand |
| Cash at beginning of period | 13.09 Million | 18.24 Million | 11.52 Million | 10.36 Million | 638.11 Thousand | 5.59 Million |
| Cash at end of period | 8.98 Million | 13.09 Million | 18.24 Million | 11.52 Million | 10.36 Million | 638.11 Thousand |
| Capital Expenditure | - | -500 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | -1.29 Million | - | - | - | - |
| Net cash flow / Change in cash | -4.11 Million | -5.14 Million | 6.71 Million | 1.15 Million | 9.72 Million | -4.96 Million |
| Free Cash Flow | -4.11 Million | -5.14 Million | -4.73 Million | -4.26 Million | -6.39 Million | -6.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.27 Million | -1.19 Million | -4.13 Million | -1.17 Million | -1.05 Million | -1.05 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 42.09 Thousand | 77.07 Thousand | 283.08 Thousand | 74.57 Thousand | 70.26 Thousand | 69.38 Thousand |
| Change in working capital | 706.77 Thousand | -41.3 Thousand | -262.72 Thousand | 303.9 Thousand | 35.65 Thousand | -287.54 Thousand |
| Other non-cash items | -829.01 Thousand | 170.16 Thousand | 546.65 Thousand | 333.49 Thousand | -126.91 Thousand | 54.43 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 16.00 | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 16.00 | 16.00 | - | - |
| Other Financing Activities | - | - | -16.00 | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 871.1 Thousand | -93.09 Thousand | -263.57 Thousand | -258.91 Thousand | 197.18 Thousand | 14.95 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -164.33 Thousand | 51.78 Thousand | 845.00 | 562.81 Thousand | -161.52 Thousand | -302.49 Thousand |
| Cash at beginning of period | 7.82 Million | 8.98 Million | 13.09 Million | 9.77 Million | 10.72 Million | 11.99 Million |
| Cash at end of period | 7.29 Million | 7.82 Million | 8.98 Million | 8.98 Million | 9.77 Million | 10.72 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -525.1 Thousand | -1.15 Million | -4.11 Million | -793.02 Thousand | -949.63 Thousand | -1.26 Million |
| Free Cash Flow | -525.1 Thousand | -1.15 Million | -4.11 Million | -793.02 Thousand | -949.63 Thousand | -1.26 Million |
CABJF
SMIT
SIFY
2728
C1X
ADANIPORTS